Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related SPKE
32 Biggest Movers From Yesterday
The Spark Energy Bull Case Is Extinguished By A Lack Of Catalysts, Analyst Says
Spark Energy declares $0.18125 dividend (Seeking Alpha)
Related MDLY
Earnings Scheduled For May 12, 2017
Earnings Scheduled For March 16, 2017

 

  • Analysts at Ladenburg Thalmann initiated coverage on Spark Energy Inc (NASDAQ: SPKE) with a Neutral rating. The price target for Spark Energy is set to $27. Spark Energy shares gained 1.17 percent to close at $26.02 on Thursday.
  • Compass Point initiated coverage of Medley Management Inc (NYSE: MDLY) with a Buy rating. The price target for Medley Management is set to $9.25. Medley Management shares fell 1.95 percent to close at $7.54 on Thursday.
  • Analysts at BTIG Research initiated coverage on Acceleron Pharma Inc (NASDAQ: XLRN) with a Buy rating. The price target for Acceleron Pharma is set to $46. Acceleron Pharma shares fell 0.03 percent to close at $30.00 on Thursday.
  • Analysts at Benchmark initiated coverage of Tegna Inc (NYSE: TGNA) with a Buy rating. The price target for Tegna is set to $26. Tegna shares slipped 0.23 percent to close at $21.30 on Thursday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Eldorado Resorts Inc (NASDAQ: ERI) with a Buy rating. Eldorado Resorts shares rose 3.02 percent to close at $14.00 on Thursday.
  • Analysts at Bernstein initiated coverage of Teck Resources Ltd (USA) (NYSE: TCK) with a Sell rating. The price target for Teck Resources is set to $10. Teck Resources shares dropped 2.91 percent to $16.02 in pre-market trading.
  • RBC Capital initiated coverage on American Midstream Partners LP (NYSE: AMID) with a Outperform rating. American Midstream shares rose 0.83 percent to close at $12.16 on Thursday.
  • Analysts at BTIG Research initiated coverage on Merrimack Pharmaceuticals Inc (NASDAQ: MACK) with a Neutral rating. Merrimack Pharmaceuticals shares gained 2.04 percent to close at $5.01 on Thursday.

Latest Ratings for SPKE

DateFirmActionFromTo
Nov 2017B. RileyDowngradesBuyNeutral
Nov 2017Janney CapitalUpgradesNeutralBuy
Jul 2017GuggenheimUpgradesNeutralBuy

View More Analyst Ratings for SPKE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ERI + AMID)

View Comments and Join the Discussion!